AtriCure Acquires Surgical Ablation Device Developer Estech

AtriCure, an atrial fibrillation medical device provider, announced it has completed the acquisition of Endoscopic Technologies, doing business as Estech.

Advertisement

Estech is a developer of surgical ablation devices that enable physicians to perform numerous traditional and minimally invasive procedures using Estech’s proprietary temperature controlled RF energy.

More Articles on Supply Chain:

Reducing Supply Chain Costs
First Navio Unicondylar Knee Replacement Performed in France
Abrams Royal Pharmacy Issues Voluntary Recall on All Unexpired Sterile Products

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.